Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients
- 1 July 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 85 (1) , 17-20
- https://doi.org/10.1016/0002-9343(88)90170-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Imipenem-cilastatin as initial therapy for febrile cancer patientsAntimicrobial Agents and Chemotherapy, 1986
- Imipenem: First of a New Class of Beta-Lactam AntibioticsAnnals of Internal Medicine, 1985
- Approaching the controversies in antibacterial management of cancer patientsThe American Journal of Medicine, 1984
- Aminoglycosides in the treatment of bacteraemic infections in the immunocompromised hostJournal of Antimicrobial Chemotherapy, 1981
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978